表紙
市場調査レポート

ゴーシェ病(I型):世界の治験レビュー

Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 303979
出版日 ページ情報 英文 88 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
ゴーシェ病(I型):世界の治験レビュー Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014
出版日: 2014年05月21日 ページ情報: 英文 88 Pages
概要

当レポートでは、ゴーシェ病(I型)の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどを提供して、概略以下の構成でお届けいたします。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:代謝障害の治験に対するゴーシェ病(I型)の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:代謝障害の治験に対するゴーシェ病(I型)の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • ゴーシェ病(I型)の治療薬の治験に参加している主要企業

有望薬

最新の治験ニュース

治験プロファイル

  • 主要企業の治験概要
    • Shire Plc
    • Sanofi
    • Amicus Therapeutics, Inc.
    • Actelion Ltd
    • ExSAR Corporation
  • 主要大学・研究機関・病院の治験概要
    • Istituto Giannina Gaslini
    • Academic Medical Center

主な臨床プロファイル

付録

図表

目次
Product Code: GDHC2142CTIDB

GlobalData's clinical trial report, "Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014" provides data on the Gaucher's Disease Type I clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gaucher's Disease Type I. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gaucher's Disease Type I. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Gaucher's Disease Type I
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Gaucher's Disease Type I
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Gaucher's Disease Type I Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Gaucher's Disease Type I
    • Oct 02, 2012: Genzyme Announces Phase III Study Of Oral Compound Eliglustat Tartrate For Gaucher Disease Meets Primary Endpoint
    • Feb 08, 2012: Genzyme Announces Four-Year Follow-Up Data From Patients Enrolled In Phase II Clinical Trial Of Eliglustat Tartrate
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Amicus Therapeutics, Inc.
      • Clinical Trial Overview of Amicus Therapeutics, Inc.
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
      • ExSAR Corporation
      • Clinical Trial Overview of ExSAR Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • Istituto Giannina Gaslini
      • Clinical Trial Overview of Istituto Giannina Gaslini
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Region, 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Gaucher's Disease Type I Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Amicus Therapeutics, Inc., 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by ExSAR Corporation, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*

List of Figures

  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Gaucher's Disease Type I Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top